ProfileGDS4132 / 216441_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 44% 48% 17% 22% 31% 41% 39% 30% 27% 22% 33% 38% 28% 19% 23% 34% 31% 28% 26% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101114.59444
GSM201543Muscle PCOS pioglitazone 121118.40248
GSM201544Muscle PCOS pioglitazone 16138.460917
GSM201545Muscle PCOS pioglitazone 20157.207822
GSM201829Muscle PCOS pioglitazone 23181.55731
GSM201830Muscle PCOS pioglitazon 251110.16541
GSM201831Muscle PCOS pioglitazone 27198.838139
GSM201832Muscle PCOS pioglitazone 3173.215930
GSM201833Muscle PCOS pioglitazone 4160.33527
GSM201834Muscle PCOS pioglitazone 8148.301622
GSM201835Muscle PCOS after pioglitazone 10268.677233
GSM201836Muscle PCOS after pioglitazone 12286.404138
GSM201837Muscle PCOS after pioglitazone 16256.262828
GSM201838Muscle PCOS after pioglitazone 20235.920819
GSM201839Muscle PCOS after pioglitazone 23248.644323
GSM201840Muscle PCOS after pioglitazone 25280.653734
GSM201841Muscle PCOS after pioglitazone 27262.230231
GSM201842Muscle PCOS after pioglitazone 3253.223528
GSM201843Muscle PCOS after pioglitazone 4260.130826
GSM201844Muscle PCOS after pioglitazone 8274.634432